Clinical Report: Evaluation of 0.55T Lung Imaging for Interstitial Lung Disease Assessment

Overview

This study evaluates the feasibility of using 0.55T MRI for assessing interstitial lung disease in patients with pulmonary sarcoidosis. It compares MRI findings with traditional chest CT imaging.

Background

Sarcoidosis can lead to significant pulmonary complications, including irreversible fibrosis. Traditional imaging methods like chest CT involve ionizing radiation, which poses risks, particularly in younger patients. The development of low-field MRI techniques offers a potential alternative for non-invasive lung assessment without radiation exposure.

Data Highlights

No numerical or trial data was provided in the source material.

Key Findings

• 15 patients with pulmonary sarcoidosis underwent both chest CT and 0.55T MRI scans.
• The mean age of the patient population was 50.2 years, with a gender distribution of 8 females and 7 males.
• A reference cohort of 30 healthy volunteers was included to establish normative values for functional lung imaging.
• Modern MRI techniques, including bSSFP, were utilized to enhance image quality.
• The study provides data on the imaging of lung morphology and function.

Clinical Implications

Further studies are needed to validate these results and establish clinical protocols.

Conclusion

Further investigation into the clinical applications of 0.55T MRI for assessing interstitial lung disease in sarcoidosis patients is warranted.

Related Resources & Content

1. European Radiology, 2024 -- Systematic Review of [18F]FDG-PET/CT Imaging in Pulmonary Sarcoidosis
2. Clinical Rheumatology, 2025 -- Evaluating Semi-Quantitative and Quantitative Approaches for Predicting Progression in Interstitial Lung Disease Linked to Rheumatoid Arthritis
3. European Radiology, 2025 -- Radiological and Histological Correlation Based on Morphology in Ultra-High-Resolution Energy-Integrating Detector CT of Cadaveric Human Lungs: Analysis of Nodules and Airways
4. Diagnosis and Detection of Sarcoidosis. An Official American Thoracic Society Clinical Practice Guideline - PMC
5. European Radiology — CT-based Quantitative Assessment of Lung Tissue to Enhance Malignancy Risk Evaluation in Incidental Pulmonary Nodules
6. A paradigm shift in corticosteroid therapy for sarcoidosis: a World Association of Sarcoidosis and Other Granulomatous Disorders Position Paper
7. Update of the international multidisciplinary classification of the interstitial pneumonias: an ERS/ATS statement
8. Diagnosis and Detection of Sarcoidosis. An Official American Thoracic Society Clinical Practice Guideline - PMC
9. Sarcoidosis: Evaluation and Treatment | AFP
10. Standardized Clinical Terms and Definitions for Interstitial Lung Disease: A Consensus Statement from the Fleischner Society | American Journal of Respiratory and Critical Care Medicine
11. Meta-analysis of [18F]FDG-PET/CT in pulmonary sarcoidosis | European Radiology | Springer Nature Link
12. Expanding Applications of Pulmonary MRI in the Clinical Evaluation of Lung Disorders: Fleischner Society Position Paper | Radiology
13. Contemporary 0.55 T MRI to visualize interstitial lung disease – An exploratory study - ScienceDirect
14. Determinants of image quality in respiratory triggered free breathing lung MRI at 0.55 T in adults - PMC
15. (ISMRM 2025) Low-Field (0.55T) Phase-resolved Functional Lung (PREFUL) MRI for Evaluating Ventilation and Perfusion in Pulmonary Diseases